Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China · Delayed Price · Currency is CNY 4.810
+0.130 (2.78%)
May 20, 2026, 2:05 PM CST
SHE:002793 Revenue
Luoxin Pharmaceuticals Group Stock had revenue of 582.73M CNY in the quarter ending March 31, 2026, a decrease of -23.97%. This brings the company's revenue in the last twelve months to 2.37B, down -2.78% year-over-year. In the year 2025, Luoxin Pharmaceuticals Group Stock had annual revenue of 2.27B, down -14.12%.
Revenue (ttm)
2.37B
Revenue Growth
-2.78%
P/S Ratio
2.14
Revenue / Employee
801.30K
Employees
2,962
Market Cap
5.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.27B | -373.91M | -14.12% |
| Dec 31, 2024 | 2.65B | 283.50M | 11.99% |
| Dec 31, 2023 | 2.36B | -1.22B | -34.11% |
| Jan 1, 2023 | 3.59B | -2.89B | -44.62% |
| Jan 1, 2022 | 6.48B | 381.70M | 6.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.59B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Beijing Beilu Pharmaceutical | 1.24B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| Zhongzhu Healthcare Holding Co.,Ltd | 544.73M |
| Beijing Science Sun Pharmaceutical | 402.62M |